these include optimising non-pharmacological means of controlling symptoms , using the smallest doses of antiasthma drugs necessary to control symptoms , basing the decision to use a drug on its benefit-to-risk ratio , avoiding recently introduced drugs ( for which safety in pregnancy has not been adequately established ) , and using the inhaled route in preference to the oral route of administration .
C0013153
route
C1527415
oral route of administration